Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta‐analysis

Volume: 23, Issue: 10, Pages: 1739 - 1747
Published: Jul 29, 2021
Abstract
This study aimed to estimate the incidence of cardiac immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICIs).First, we performed an ICI pharmacovigilance analysis, finding 4.2% of cardiac disorders, including myocarditis, for anti-CTLA-4, anti-PD-1, and anti-PD-L1 therapies. Patients treated with anti-PD-1 antibodies presented a greater number of cardiac adverse events (AEs) than those treated with...
Paper Details
Title
Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta‐analysis
Published Date
Jul 29, 2021
Volume
23
Issue
10
Pages
1739 - 1747
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.